FUND | HOLDING | % OF FUND | VALUE ($) |
---|---|---|---|
IXJ | Eli Lilly and (LLY) | 8.649% | $323.7M |
IXJ | Johnson & Johnson (JNJ) | 5.304% | $198.5M |
IXJ | AbbVie (ABBV) | 4.745% | $177.6M |
IXJ | UnitedHealth (UNH) | 3.903% | $146.1M |
IXJ | Abbott Laboratories (ABT) | 3.331% | $124.7M |
IXJ | Intuitive Surgical (ISRG) | 2.854% | $106.8M |
IXJ | Merck (MRK) | 2.815% | $105.4M |
IXJ | Amgen (AMGN) | 2.211% | $82.8M |
IXJ | Thermo Fisher Scientific (TMO) | 2.185% | $81.8M |
IXJ | Boston Scientific (BSX) | 2.173% | $81.3M |
IXJ | Gilead Sciences (GILD) | 1.974% | $73.9M |
IXJ | Stryker (SYK) | 1.883% | $70.5M |
IXJ | Pfizer (PFE) | 1.878% | $70.3M |
IXJ | Danaher (DHR) | 1.763% | $66M |
IXJ | Vertex Pharmaceuticals (VRTX) | 1.634% | $61.2M |
IXJ | Medtronic (MDT) | 1.597% | $59.8M |
IXJ | Bristol-Myers Squibb (BMY) | 1.39% | $52M |
IXJ | Elevance Health (ELV) | 1.277% | $47.8M |
IXJ | McKesson (MCK) | 1.276% | $47.8M |
IXJ | Cigna (CI) | 1.222% | $45.7M |
IXJ | CVS Health (CVS) | 1.14% | $42.7M |
IXJ | Zoetis (ZTS) | 1.081% | $40.5M |
IXJ | HCA (HCA) | 0.977% | $36.6M |
IXJ | Regeneron Pharmaceuticals (REGN) | 0.731% | $27.4M |
IXJ | CoreSite Realty (COR) | 0.713% | $26.7M |